# ZYKADIA

NDC: 0078-0694
Generic name: ceritinib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190318

FDA application: NDA211225

## Active ingredients

- CERITINIB: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0694"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0694
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fff5d805-4ffd-4e8e-8e63-6f129697563e